Published Date : Nov 21, 2016
ALBANY, NY, Nov 21, 2016: The report offers a comprehensive outlook of the global market for animal antibacterial and antibiotics, observing the competitive landscape, profiling some of the key players, and analyzing the impact of all the significant drivers and restraints. The report estimates a healthy CAGR of 6.5% during the forecast period of 2016 to 2020.
The overview section of the report explores the basic purposes of antibacterial and antibiotic drugs. For example, these drugs are used to treat various conditions that affect animals such as companion animals, cattle, horses, fish, and swine. Antibacterial and antibiotic drugs are also used to accelerate the growth of animals in the regions of North America and Europe. However, the report notes a worrying trend: the overuse of these antibiotics has led to the development of antibiotic-resistant strains of microorganisms, which can be transferred to humans through the consumption of milk or meat.
For the benefit of new market players, this 71-page report dedicates a chapter explaining the process of drug approval such as NADAs and supplements, ANADAs and supplements, and CNADAs. To calculate the market size, the report considers the revenue generated from the sales of generic, branded, and off-label drugs.
According to this market research study, some of the factors driving the global market for animal antibacterial and antibiotics include the increasing demand for protein-rich diet, a rise in the incidence of zoonotic diseases, and an increase in animal ownership among the urban population. Urban folks can not only afford these antibiotics and antibacterial drugs for their companion animals but are also aware of the long-term benefits. However, the report finds that lengthy regulatory approval processes, an increase in antibiotic resistance in bacteria, and reduced visits to veterinary clinics are some of the prominent challenges that may hinder the overall growth rate of the global market for animal antibacterial and antibiotics. The eventual impact of all these drivers and restraints are explored in detail in the report.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/850969
The report also reveals and explains some of the emerging trends in the global market for animal antibacterial and antibiotics, such as industry-academia collaborations, an increase in investments, and vertical integration in the livestock industry.
To present a clear picture, the report segments the animal antibacterial and antibiotics market in terms of chemical class and geographies. By chemical class, the global market has been divided into tetracycline and others, while by geography, the market has been categorized into the Americas, APAC, and EMEA.
Some of the top vendors in the global market for animal antibacterial and antibiotics are Zoetis, Merial, Elanco, Merck Animal Health, and Bayer HealthCare. Other prominent vendors include Boehringer Ingelheim Vetmedica, Dechra Pharmaceuticals, Bio-Vet, Animal Medics, Biognesis Bag, Mobedco-Vet (The Arab Pesticides & Veterinary Drugs), Ceva Sant Animale, ECO Animal Health, Huvepharma, Indian Immunologicals, Lillidale Animal Health, Phibro Animal Health, Vtoquinol, Virbac, Neogen, Norbrook, Orion, and Vitafor.
To order report Call Toll Free: 866-997-4948 or send an email on email@example.com